November 12, 2026 at 11:15 AM UTC
8-K - enGene Therapeutics Inc. (0001980845) (Filer)
Filed: 2026-11-12 AccNo: 0001193125-26-456703 Size: 37 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Official source: U.S. Securities and Exchange Commission
Official source published: November 12, 2026 at 11:14 AM UTC
Open official source